SCOTUS suggests willingness to finally tackle patent enablement standard
The US Supreme Court seeks Solicitor General’s input on whether take up controversial section 112 questions
The US Supreme Court seeks Solicitor General’s input on whether take up controversial section 112 questions
The INPI harnessed examination work done abroad as well as cutting-edge technology to reduce pileup of applications by 80%
Japan’s Maxell has been hit with court actions and patent invalidations in China by lithium ion battery supplier ATL
UK court sides with the drug company on key counterfactual assumptions in high-stakes compensation battle with the NHS and generics
03 August 2021
CATL sees injunction opportunity as competition among domestic players heats up
30 July 2021
A recent decision puts selection drug patents in jeopardy
29 July 2021
The FTC is likely to make new rules on reverse-payment settlements, but there could be significant pushback
27 July 2021
Two founders of JHL Biotech have recently been indicted for conspiracy to steal trade secrets from the Californian company, while two other individuals pleaded guilty to similar charges
23 July 2021
The number and value of acquisitions have both tumbled further than in the early months of 2020
20 July 2021
US president abandons Trump-era proposal to rule out patent suspensions under the Bayh-Dole Act
16 July 2021
What the final implementing measures of the Hatch-Waxman-style framework mean for biopharma patentees and generics
15 July 2021
A recent report into supplementary protection certificates provides crucial insights for IP strategists and policy-makers
08 July 2021
Country’s National Health Service fails to overturn rules on damages sought by healthcare providers affected by failed enforcement
07 July 2021
Get unlimited access to all IAM content